Curefoods is expecting to reach annual recurring revenue (ARR) of Rs 1000 crore ($122 million) by the end of this year and it aims to be ready for an IPO in 18 months
Despite this decline, 2022 marks the second-best year for PE/VC investments in India to date; dip largely due to smaller deal sizes amid stable volumes
Thomas says the bank expects to bring the microfinance portfolio down to 60 per cent of its book
Platform reliability, time to meet margin calls are other key criteria for traders while selecting a broker
Through financial modelling, experts arrive at a fair value that ranges between Rs 145 and Rs 360
In Sebi's parlance, its observation implies its go ahead to launch the initial share-sale
Currently, promoter and promoter group hold 66.70 per cent stake in the company and the rest is with public shareholders
The company may consider a private placement of equity shares for up to Rs 150 crore. If such placement is completed, the fresh issue size will be reduced
The proposed IPO comprises fresh issuance of equity shares worth up to Rs 500 crore and an offer for sale (OFS) component of 4,37,27,603 equity shares
Pharmaceutical companies Innova Captab Ltd and Blue Jet Healthcare have received Sebi's go-ahead to raise funds through initial public offering (IPO)
Market players said the selling could be because of fears around further sell-downs by existing investors
The stock rallied 7% to hit a new high of Rs 612.70 in the intra-day trade today
How will RS Sodhi's departure affect Amul? Why is the Oyo IPO getting delayed? Can new launches at Auto Expo 2023 put auto stocks in top gear? What is the Montreal Protocol? All answers here
Electronic Manufacturing Services (EMS) firm Cyient DLM Ltd has filed preliminary papers with capital markets regulator Sebi to raise Rs 740 crore through an Initial Public Offering (IPO)
The IPO comprises a fresh issue of equity shares and an offer for sale (OFS)
Price range for the offer was at Rs 61-65 a share
The deal resolves a key hurdle for Ant as it seeks to meet requirements from regulators following a crackdown on its business after its record initial public offering was torpedoed in 2020
HealthKart operates two verticals in the Indian market, MuscleBlaze, a sports nutrition brand, and HKVitals, an online health supplement brand
Sources are expecting IPO in October-December quarter of this year
The IPO received bids for 1,33,06,420 shares against 56,10,000 shares on offer, according to NSE data